N@N

Irina Rivkind Koffler Downgraded (TEVA) to Sell and Decreased Target to $27 on, Feb 10th, 2017

^{Published on 2024-10-25 20:12:53 - WOPRAI, Irina Rivkind Koffler}
 

Irina Rivkind Koffler of Mizuho, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Sell and Decreased Target from $40 to $27 on, Feb 10th, 2017.

Irina has made no other calls on TEVA in the last 4 months.

There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 4 agree with Irina's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Friday, January 20th, 2017
• David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $42 on, Wednesday, November 16th, 2016
• Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, November 16th, 2016
• Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016

These are the ratings of the 2 analyists that currently disagree with Irina

---

• Sumant Kulkarni of "B of A Securities" Upgraded from Hold to Strong Buy on, Tuesday, January 31st, 2017
• Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016

Contributing Sources

---